# Synapticure

> Synapticure is a Chicago-based virtual specialty neurology practice built by ALS patient and advocate Brian Wallach, caregiver and CEO Sandra Abrevaya, and a founding team with healthcare and technology experience. It gives patients and caregivers across all 50 states access to subspecialist neurologists, personalized treatment, behavioral health, genetic counseling, speech therapy, care navigation, insurance support, remote monitoring, and clinical-trial guidance. The company serves people directly and works with health plans, health systems, accountable care organizations, clinics, and advocacy groups, positioning itself between conventional neurology practices and general-purpose telehealth.

- **Founded:** 2019
- **Headquarters:** Chicago, United States
- **Founders:** Sandra Abrevaya (Co-Founder and CEO), Brian Wallach (Co-Founder and Board Co-Chair), Peter Wallach (Co-Founder and CFO), Jason Langheier (Co-Founder and Board Co-Chair), Jonathan Hirsch (Co-Founder and Board of Advisors Chair)
- **Team size:** Approximately 110 employees in the supplied company record; LinkedIn lists 51-200 employees.
- **Products:** Virtual neurology consultations, Interdisciplinary wraparound care, Genetic testing and counseling, Clinical-trial and treatment navigation, Remote respiratory monitoring
- **Notable:** Expanded from an ALS-focused launch to cognitive, movement and neuromuscular care across all 50 states., Raised a $25 million Series A in November 2024 led by B Capital., Selected as an established CMS GUIDE participant for dementia care across all 50 states.

## Products & services

- **Virtual neurology consultations** — Remote diagnosis, second opinions, treatment planning and longitudinal care from neurologists specializing in cognitive, movement and neuromuscular disorders.
- **Interdisciplinary wraparound care** — Care coordination, behavioral health, speech-language therapy, medication review, caregiver education, insurance navigation and 24/7 support options.
- **Genetic testing and counseling** — Testing coordination plus counseling before and after results, including help interpreting uncertain findings and treatment implications.
- **Clinical-trial and treatment navigation** — Identification of relevant research studies and emerging therapies, with records preparation and enrollment guidance.
- **Remote respiratory monitoring** — An at-home spirometry program introduced for people living with ALS to help monitor respiratory function.
- **CMS GUIDE dementia services** — Care planning, 24/7 coordination, caregiver support and eligible respite services for qualifying traditional Medicare beneficiaries with dementia.
- **Partner care platform** — A virtual specialty service line for health plans, health systems, ACOs and provider groups, including referral workflows, co-management and analytics.

## Achievements

- Expanded from an ALS-focused launch to cognitive, movement and neuromuscular care across all 50 states.
- Raised a $25 million Series A in November 2024 led by B Capital.
- Selected as an established CMS GUIDE participant for dementia care across all 50 states.
- Earned The Joint Commission Gold Seal of Approval for Ambulatory Health Care Accreditation in 2024.
- Reported serving several thousand patients nationwide by November 2024.
- Company-reported partner data show appointments averaging about one week from intake, a 96 Net Promoter Score and 99% retention excluding death.
- Company-reported outcomes after six or more months enrolled include 19% fewer emergency-department visits and 12% fewer inpatient admissions compared with the preceding 12 months.

## Latest updates

- **2026-06** — MyBrainGuide, created by UsAgainstAlzheimer’s, added a pathway for users to connect with Synapticure dementia intake teams and specialists.
- **2026-04** — Synapticure expanded its virtual specialty offering to include dedicated ataxia care, with support from the National Ataxia Foundation’s Access to Care Everywhere initiative.
- **2025-08** — The company published an origin-and-impact review describing its three-pillar model: expert care, clinical-trial navigation and research acceleration.
- **2025-03** — Synapticure detailed its high-touch model built around longitudinal relationships with the same interdisciplinary care team.
- **2024-11** — Closed a $25 million Series A to expand national care partnerships, technology, analytics and research.
- **2024-08** — Partnered with Pearl Health to support Medicare patients living with dementia.
- **2024-04** — Announced a nationwide telehealth partnership with The ALS Association and earned Joint Commission ambulatory accreditation.

## Links

- Website: https://www.synapticure.com
- LinkedIn: https://www.linkedin.com/company/synapticure-inc
- Twitter/X: https://x.com/synapticure
- YouTube: https://www.youtube.com/@synapticure
- Instagram: https://www.instagram.com/synapticurehealth
- Facebook: https://www.facebook.com/synapticure/

---

Profile page: https://yespress.io/synapticure
Published by YesPress — https://yespress.io
Last updated: 2026-08-18